Promising Role of Circulating Tumor Cells in the Management of SCLC

SIMPLE SUMMARY: Despite the recent approval of immune-checkpoint inhibitors, therapeutic strategies for the treatment of small-cell lung cancer (SCLC) patients remained unchanged for decades. The aggressiveness of the disease and the lack of active treatments underlie the need for the identification...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Antonella, Gallo, Marianna, Esposito, Claudia, Morabito, Alessandro, Normanno, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122820/
https://www.ncbi.nlm.nih.gov/pubmed/33922300
http://dx.doi.org/10.3390/cancers13092029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122820/
https://www.ncbi.nlm.nih.gov/pubmed/33922300
http://dx.doi.org/10.3390/cancers13092029

Ejemplares similares